Understanding the Efficacy of Dietary Supplement on Fungal Mycobiota in Healthy Volunteers: A Pilot Study
In plain words A Phase 4 study of DL-Phenylalanine in people 18 and older, run by Weill Medical College of Cornell University. It plans to enroll about 20 people at 1 US site.
Who it lists and where
Who the trial lists, as registered
Lists people 18 and older; healthy volunteers accepted. Conditions: Gut Microbiome; Gut Health; Dietary Supplement; L-Phenylalanine; Phenylpropionic Acid.
- Male or female adults over the age of 18 years
The exclusion criteria are on the listing.
What it tests, as registered
L-Phenylalanine 500 mg Veg Capsule product
Registered summary
The purpose of this study is to explore how the dietary supplement L-Phenylalanine affects the production of the metabolite phenylpropionic acid (PPA) and changes fungal populations of the gut microbiome.
Where, as registered
1 US site in 1 state.